U.N. Secretary-General Ban Ki-Moon on Monday called for countries around the world to "renew their commitment to educate girls, end sexual violence, and provide access to modern birth control," the Associated Press/Washington Post reports.
Two new studies on the effects of epilepsy drugs taken during pregnancy show mixed results. The risk of birth defects with a newer drug, lamotrigine, was similar to that in women without epilepsy.
Covidien plc, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced that it has completed the previously announced acquisition of Newport Medical Instruments, Inc. for an aggregate consideration of approximately $108 million, net of cash and short-term investments acquired.
Republicans are continuing to pressure officials at the Department of Health and Human Services on health reform as the focus shifts to implementation of the health care overhaul and the first deadlines are approaching, Politico reports.
Texas' move and subsequently imminent loss of federal Medicaid money has sparked a protest. Lawmakers in New Hampshire and Minnesota are examining the federal contraception coverage requirement.
Immdal Limited ('Immdal'), a privately held Irish pharmaceutical healthcare group, today announced the sale of its subsidiary Newport Pharmaceuticals Limited ('Newport') to Swiss pharmaceutical company Ewopharma AG.
A Knoxville abortion provider has closed after 38 years, citing a newly enacted Tennessee law that requires doctors to hold admitting privileges at local hospitals. The Volunteer Women's Medical Clinic in Knoxville closed Friday. In a public letter titled "End of an Era," Executive Director Deb Walsh wrote that she was unable to keep their doors open in part due to the "Life Defense Act," which requires physicians to obtain admitting privileges at area hospitals.
With impending lawsuits from states, an uprising from the Tea Party sect and an outpouring of rhetoric from both major parties, the healthcare debate is far from over.